BioWorld

Dec. 1, 2003

View Archived Issues

Praecis Gets First Approval: Plenaxis In Prostate Cancer

Prostate cancer patients gained a new treatment option on Nov. 25 as the FDA approved Plenaxis, a drug fully developed by Praecis Pharmaceuticals Inc. (BioWorld Today) Read More

Genentech's Avastin Misses Primary Endpoint In Phase II

Read More

Largest Stroke Trials Worldwide Compare Oral Anti-Ischemic Drugs With Current Warfarin Prevention

Read More

Medicare Bill To White House; Most Applaud New Regulations

Read More

Holiday Notice

Read More

Chronogen Series B Raises C$17M For Longevity Work

Read More

Other News To Note

Read More